EUR 3.52
(-1.4%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -2.24 EUR | 62.03% |
2022 | -5.90 EUR | -40.14% |
2021 | -4.21 EUR | -665.45% |
2020 | -0.55 EUR | -965.89% |
2019 | -0.05 EUR | -10220.0% |
2018 | -0.00 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 FY | - EUR | 62.03% |
2023 Q2 | - EUR | 0.0% |
2022 Q2 | -0.30 EUR | 0.0% |
2022 Q4 | - EUR | 100.0% |
2022 FY | - EUR | -40.14% |
2021 FY | - EUR | -665.45% |
2021 Q2 | -0.16 EUR | 44.83% |
2020 Q2 | -0.04 EUR | 0.0% |
2020 FY | - EUR | -965.89% |
2020 Q4 | -0.29 EUR | -597.12% |
2019 FY | - EUR | -10220.0% |
2018 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
MPH Health Care AG | 6.90 EUR | 132.464% |
Apontis Pharma AG | -1.33 EUR | -68.421% |
Dermapharm Holding SE | 1.16 EUR | 293.103% |
Evotec SE | -0.47 EUR | -376.596% |
MERCK Kommanditgesellschaft auf Aktien | 6.50 EUR | 134.462% |
PharmaSGP Holding SE | 1.37 EUR | 263.504% |